We randomly allocated participants ( @:@ ) according to permuted blocks , stratified by germline BRCA status and previous anti-angiogenic therapy , to receive olaparib capsules @ mg twice daily or the combination at the recommended phase @ dose of cediranib @ mg daily and olaparib capsules @ mg twice daily .